ESTEE LAUDER COMPANIES INC EL

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived NYSE

The Estée Lauder Companies Inc., founded in 1946 by Estée and Joseph Lauder, is one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. We are a steward of over 20 luxury and prestige brands globally. Since the initial launch of the Estée Lauder brand in the United States, we have significantly expanded our consumer reach to approximately 150 countries and territories. We operate as a wholesaler, with our products sold in brick-and-mortar locations and on various e-commerce platforms, including those operated by department stores, duty-free retailers, specialty-multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas. Additionally, we operate a direct-to-consumer business across freestanding stores, our brands' websites and third-party online platforms.

Last close 108.67 2026-10-23
Market cap $39.37B estimated share count
52-week range 66.22 - 121.64

Valuation FY2026 figures against the last close

P/S2.6x
P/E217.3x
P/FCF29.9x
EV/EBITDA23.1x
Dividend yield1.3%
Diluted EPS0.50

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • All other countries
  • Mainland China
  • U.S.
Revenue by geography, 3 categories over 3 years. The same figures are in the table below. FY2026 All other countries, FY2026: 7.4B (49.0%) 49% All other countries Mainland China, FY2026: 3.9B (26.1%) 26% Mainland China U.S., FY2026: 3.7B (24.9%) 25% U.S. FY2025 All other countries, FY2025: 6.9B (48.2%) 48% Mainland China, FY2025: 3.7B (25.5%) 25% U.S., FY2025: 3.8B (26.3%) 26% FY2024 All other countries, FY2024: 7.7B (49.3%) 49% Mainland China, FY2024: 4B (25.7%) 26% U.S., FY2024: 3.9B (24.9%) 25%
Region FY2026FY2025FY2024
All other countries $7.37B $6.91B $7.70B
Mainland China $3.93B $3.65B $4.02B
U.S. $3.75B $3.76B $3.89B

As the company reported it, from the “SEGMENT DATA AND RELATED INFORMATION - Schedule of Revenue by Geographical Location (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue $15.05B$14.33B$15.61B$15.91B$17.74B$16.21B$14.29B$14.86B$13.68B$11.82B
Cost of revenue $3.69B$3.73B$4.42B$4.56B$4.30B$3.83B$3.55B$3.39B$2.84B$2.43B
Gross profit $11.36B$10.60B$11.18B$11.35B$13.43B$12.38B$10.74B$11.48B$10.84B$9.39B
SG&A $9.69B$9.46B$9.62B$9.57B$9.89B$9.37B$8.64B$8.86B$8.55B$7.46B
Total operating expenses $10.58B$11.38B$10.21B$9.84B$10.26B$9.76B$10.14B$9.16B$8.78B$7.69B
Operating income $780.0M-$785.0M$970.0M$1.51B$3.17B$2.62B$606.0M$2.31B$2.06B$1.70B
Interest expense $334.0M$357.0M$378.0M$255.0M$167.0M$173.0M$161.0M$133.0M$128.0M$103.0M
Pre-tax income $517.0M-$1.04B$772.0M$1.40B$3.04B$3.33B$1.05B$2.31B$1.98B$1.62B
Income tax $335.0M$93.0M$363.0M$387.0M$628.0M$456.0M$350.0M$513.0M$863.0M$361.0M
Net income $182.0M-$1.13B$409.0M$1.01B$2.41B$2.88B$696.0M$1.79B$1.11B$1.26B
EPS, basic 0.50-3.151.092.816.647.911.904.913.013.40
EPS, diluted 0.50-3.151.082.796.557.791.864.822.953.35
Shares, diluted (wtd. avg.) 364.8M360.1M360.8M360.9M364.9M368.2M366.9M370.4M375.7M373.0M

Balance sheet

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents $3.50B$2.92B$3.40B$4.03B$3.96B$4.96B$5.02B$2.99B$2.18B$1.14B
Short-term investments ————————$534.0M$605.0M
Receivables $1.52B$1.53B$1.73B$1.45B$1.63B$1.70B$1.19B$1.83B$1.49B$1.40B
Inventory $2.00B$2.07B$2.17B$2.98B$2.92B$2.50B$2.06B$2.01B$1.62B$1.48B
Total current assets $7.61B$7.07B$7.92B$9.14B$9.30B$9.77B$8.89B$7.21B$6.17B$4.96B
Property, plant and equipment $2.81B$3.17B$3.14B$3.18B$2.65B$2.28B$2.06B$2.07B$1.82B$1.67B
Goodwill $2.11B$2.13B$2.14B$2.49B$2.52B$2.62B$1.40B$1.87B$1.93B$1.92B
Other intangibles $3.58B$3.76B$5.18B$5.60B$3.43B$4.09B$2.34B$1.20B$1.28B$1.33B
Total assets $19.76B$19.89B$21.68B$23.41B$20.91B$21.97B$17.78B$13.16B$12.57B$11.57B
Short-term debt $503.0M$3.0M$504.0M$997.0M$268.0M$32.0M$1.22B$516.0M$183.0M$189.0M
Total current liabilities $6.23B$5.43B$5.70B$6.24B$5.82B$5.30B$5.18B$4.61B$3.31B$2.82B
Total liabilities ———————$8.74B——
Retained earnings $11.34B$11.67B$13.43B$13.99B$13.91B$12.24B$10.13B$9.98B$9.04B$8.45B
Total equity $3.81B$3.87B$5.31B$5.58B$5.59B$6.09B$3.96B$4.39B$4.71B$4.40B

Cash flow

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating cash flow $1.77B$1.27B$2.36B$1.73B$3.04B$3.63B$2.28B$2.52B$2.56B$1.79B
Depreciation and amortisation $796.0M$829.0M$825.0M$744.0M$727.0M$651.0M$611.0M$557.0M$531.0M$464.0M
Stock-based compensation $310.0M$304.0M$325.0M$267.0M$331.0M$327.0M$213.0M$243.0M$236.0M$219.0M
Capital expenditure $457.0M$602.0M$919.0M$1.00B$1.04B$637.0M$623.0M$744.0M$629.0M$504.0M
Investing cash flow -$489.0M-$623.0M-$960.0M-$3.22B-$945.0M-$1.86B-$1.70B$473.0M-$358.0M-$2.20B
Financing cash flow -$712.0M-$1.14B-$2.04B$1.59B-$3.04B-$1.89B$1.46B-$2.17B-$1.17B$630.0M
Dividends paid $508.0M$618.0M$947.0M$925.0M$840.0M$753.0M$503.0M$609.0M$546.0M$486.0M
Buybacks $70.0M$35.0M$35.0M$271.0M$2.31B$733.0M$893.0M$1.55B$759.0M$413.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001001250-26-000041.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B 20B Revenue, FY2017: 11.8B Gross profit, FY2017: 9.4B Net income, FY2017: 1.3B Revenue, FY2018: 13.7B Gross profit, FY2018: 10.8B Net income, FY2018: 1.1B Revenue, FY2019: 14.9B Gross profit, FY2019: 11.5B Net income, FY2019: 1.8B Revenue, FY2020: 14.3B Gross profit, FY2020: 10.7B Net income, FY2020: 696M Revenue, FY2021: 16.2B Gross profit, FY2021: 12.4B Net income, FY2021: 2.9B Revenue, FY2022: 17.7B Gross profit, FY2022: 13.4B Net income, FY2022: 2.4B Revenue, FY2023: 15.9B Gross profit, FY2023: 11.3B Net income, FY2023: 1B Revenue, FY2024: 15.6B Gross profit, FY2024: 11.2B Net income, FY2024: 409M Revenue, FY2025: 14.3B Gross profit, FY2025: 10.6B Net income, FY2025: -1.1B Revenue, FY2026: 15B Gross profit, FY2026: 11.4B Net income, FY2026: 182M FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026
Fiscal year FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue $11.82B $13.68B $14.86B $14.29B $16.21B $17.74B $15.91B $15.61B $14.33B $15.05B
Gross profit $9.39B $10.84B $11.48B $10.74B $12.38B $13.43B $11.35B $11.18B $10.60B $11.36B
Net income $1.26B $1.11B $1.79B $696.0M $2.88B $2.41B $1.01B $409.0M -$1.13B $182.0M

Recent filings and events

  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Restructuring or exit costs A restructuring: layoffs, a plant closure, a business being wound down. Item 2.05
  • Restructuring or exit costs Item 2.05
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Restructuring or exit costs Item 2.05
  • Other event Item 8.01
  • Results announced Item 2.02
  • Restructuring or exit costs Item 2.05
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
IPAR INTERPARFUMS INC $3.69B 22.0x 2.5%
COTY COTY INC. $2.84B — -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.29B 52.9x -1.3%
WALD Waldencast plc $100.3M — -0.7%
SLSN SOLESENCE, INC. $56.5M 40.0x 18.6%